
Minimolide F
CAS No. 1367351-41-4
Minimolide F( —— )
Catalog No. M29324 CAS No. 1367351-41-4
Minimolide F, isolated from Centipeda minima, shows antiproliferative activity against human nasopharyngeal cancer cells with an IC50 of 17.4 μM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 218 | Get Quote |
![]() ![]() |
5MG | 335 | Get Quote |
![]() ![]() |
10MG | 537 | Get Quote |
![]() ![]() |
25MG | 842 | Get Quote |
![]() ![]() |
50MG | 1134 | Get Quote |
![]() ![]() |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameMinimolide F
-
NoteResearch use only, not for human use.
-
Brief DescriptionMinimolide F, isolated from Centipeda minima, shows antiproliferative activity against human nasopharyngeal cancer cells with an IC50 of 17.4 μM.
-
DescriptionMinimolide F, isolated from Centipeda minima, shows antiproliferative activity against human nasopharyngeal cancer cells with an IC50 of 17.4 μM.
-
In VitroMinimolide F has antiproliferative activity and can inhibit the CNE cell growth.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1367351-41-4
-
Formula Weight334.41
-
Molecular FormulaC19H26O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[C@]12[C@]3([C@@]([C@@H](OC(C(C)C)=O)C1)([C@H](C)C[C@@]4([C@](C3)(C(=C)C(=O)O4)[H])[H])[H])O2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog



related products
-
6-Chloro-1-tetralone
6-Chloro-1-tetralone is an important intermediate for the synthesis of pharmaceutical compounds.
-
(+)-Lyoniresinol
Lyoniresinol is a lignan isolated from Tarenna attenuata with free radical scavenging activity (IC50 of 82.4 μM) and antioxidant activity of DPPH, showing anti-melanogenic activity.
-
PUMA BH3 (TFA)
PUMA BH3 (TFA) is a p53 upregulated modulator of apoptosis (PUMA) BH3 domain peptide, acts as a direct activator of Bak, with a Kd of 26 nM.